Perioperative Cardiac Risk Assessment Using RCRI and Enhanced Strategies

RCRI as the Primary Risk Stratification Tool

• The American College of Cardiology/American Heart Association (AHA/ACC) guidelines endorse the Revised Cardiac Risk Index (RCRI) as a validated instrument that predicts the probability of major adverse cardiac events (MACE — myocardial infarction, cardiac arrest, pulmonary edema, ventricular fibrillation, or complete heart block) in the peri‑operative period【1】【2】.
• The 2024 AHA/ACC guideline recommends using an RCRI > 1 or a calculated MACE risk > 1 % as the threshold to identify patients at elevated cardiac risk【3】【4】【5】.
• The RCRI assigns one point for each of six predictors: (1) history of ischemic heart disease, (2) congestive heart failure, (3) cerebrovascular disease, (4) insulin‑dependent diabetes, (5) chronic kidney disease (creatinine > 2 mg/dL), and (6) high‑risk surgery【1】【2】.
• Risk categories:
  
  • RCRI 0‑1 (low risk): < 1 % predicted MACE; proceed to surgery without additional cardiac testing【3】【4】.
  • RCRI = 2 (moderate risk): 4‑7 % predicted MACE; assess functional capacity and, if ≥ 4 METs, proceed to surgery【1】.
  • RCRI ≥ 3 (high risk): 9‑11 % predicted MACE; implement comprehensive cardiac monitoring and consider stress testing only if results would change management【1】.

Augmenting RCRI with Functional Capacity Assessment

• The guideline recommends measuring pre‑operative functional capacity with the Duke Activity Status Index (DASI) for patients with RCRI ≥ 1 undergoing elevated‑risk surgery【3】【5】 (Class IIa).

Biomarker Enhancement

• Pre‑operative BNP/NT‑proBNP (Class IIa): Adding BNP or NT‑proBNP to the RCRI improves discrimination—median Δc‑statistic = 0.15 for BNP and = 0.08 for NT‑proBNP compared with RCRI alone【3】【5】.
• Abnormal biomarker thresholds: troponin > 99th percentile, BNP > 92 ng/L, NT‑proBNP ≥ 300 ng/L are considered elevated and trigger heightened peri‑operative vigilance【3】【4】【5】.

Alternative Risk Calculators

• When the RCRI may be insufficient (e.g., vascular surgery), the ACS NSQIP Myocardial Infarction and Cardiac Arrest (MICA) calculator—incorporating 21 variables—demonstrates superior predictive discrimination, with a median Δc‑statistic ≈ 0.11 higher than the RCRI for predicting peri‑operative MI and cardiac arrest【1】.

Recommendations on Additional Testing

• Stress testing: Should be ordered only if the patient has poor functional capacity (< 4 METs) or unknown capacity and the results are likely to alter management (e.g., lead to coronary revascularization, medication changes, or surgical cancellation)【1】【3】 (Class IIb).
• Routine pre‑operative coronary angiography: Not recommended for improving peri‑operative outcomes (Class III: No Benefit)【3】.

Perioperative Cardiac Risk Assessment using the Revised Cardiac Risk Index (RCRI)

Introduction to RCRI

• The RCRI is a validated tool for estimating perioperative major adverse cardiac events (MACE) in patients with known cardiovascular disease undergoing non-cardiac surgery, with risk stratification based on the number of clinical predictors present 6, 7, 8

Risk Stratification

• The RCRI score directly correlates with perioperative MACE risk, ranging from <1% for low-risk patients to 9-11% for high-risk patients 9
• Patients with RCRI = 0 (Class I) have a 0.4-0.5% risk of MACE, and can proceed directly to surgery without additional cardiac testing 9, 10
• Patients with RCRI = 1 (Class II) have a 0.9-1.3% risk of MACE, and can proceed to surgery without additional testing 9, 10
• Patients with RCRI = 2 (Class III) have a 4-7% risk of MACE, and should assess functional capacity and consider additional testing only if poor functional capacity (<4 METs) and results would change management 9, 10
• Patients with RCRI ≥3 (Class IV) have a 9-11% risk of MACE, and should implement comprehensive cardiac monitoring and consider surveillance for myocardial injury after non-cardiac surgery 9, 10

Clinical Application

• The American College of Surgeons recommends using the RCRI to assess perioperative cardiac risk in patients undergoing non-cardiac surgery 10
• For patients with RCRI ≥2, consider pharmacological stress testing if poor functional capacity and results would impact management 11, 9
• For patients with RCRI ≥3, implement comprehensive cardiac monitoring during surgery and consider postoperative surveillance for myocardial injury after non-cardiac surgery (MINS) 11

Enhancing RCRI Predictive Power

• Adding functional capacity assessment to RCRI significantly increases its predictive power 12, 10
• DASI scores ≤34 are associated with increased odds of 30-day death or MI 12
• The combination of RCRI with DASI provides superior risk stratification compared to RCRI alone 10

Alternative Risk Assessment Tools

• The American College of Surgeons NSQIP MICA calculator uses 21 components and may provide superior predictive discrimination, particularly in broader surgical populations 10
• The universal ACS NSQIP Surgical Risk Calculator provides procedure-specific risk estimates for multiple outcomes and may be preferred for comprehensive perioperative risk assessment 10

Perioperative Cardiovascular Risk Assessment and Management for Non‑Cardiac Surgery

1. Core Risk Stratification Tool

• The Revised Cardiac Risk Index (RCRI) should be used as the primary peri‑operative risk stratification instrument, assigning one point for each of six predictors: ischemic heart disease, heart failure, cerebrovascular disease, insulin‑dependent diabetes, chronic kidney disease (creatinine > 2 mg/dL), and high‑risk surgery. 13

2. Management According to RCRI Score

2.1 Low‑Risk Patients (RCRI 0‑1; <1 % MACE)

• Patients with an RCRI of 0‑1 can proceed directly to surgery without additional cardiac testing; stress testing or coronary angiography is not indicated. Observed event rates are 0.4‑0.5 % for RCRI 0 and 0.9‑1.3 % for RCRI 1. 13

2.2 Moderate‑Risk Patients (RCRI 2; 4‑7 % MACE)

• Assess functional capacity with the Duke Activity Status Index (DASI).
• If functional capacity is ≥4 METs (e.g., able to climb two flights of stairs), proceed to surgery without further cardiac testing.
• If functional capacity is <4 METs or unknown, consider pharmacologic stress testing only when the results would change management (e.g., lead to revascularization, medication adjustment, or surgical cancellation). Observed event rate is 4‑7 %. 13

2.3 High‑Risk Patients (RCRI ≥3; 9‑11 % MACE, up to 14.4 % in some cohorts)

• Implement comprehensive peri‑operative cardiac monitoring.
• Evaluate functional capacity with DASI; if <4 METs, stress testing is considered only if the outcome would alter management.
• Consider postoperative troponin surveillance to detect myocardial injury after non‑cardiac surgery (MINS). Observed event rate is 9‑11 % (up to 14.4 % in selected cohorts). 13

3. Enhancing Risk Prediction

3.1 Functional Capacity Assessment (Class IIa)

• Use the DASI questionnaire for patients with RCRI ≥1 undergoing elevated‑risk surgery.
• DASI scores ≤34 are associated with higher odds of 30‑day death or myocardial infarction.
• The 12‑item DASI yields a weighted score ranging from 0 to 58.2 based on activities from self‑care (2.75 points) to strenuous sports (7.5 points).
• Functional capacity <4 METs confers a 1.63‑fold higher rate of death, MI, acute heart failure, or life‑threatening arrhythmias. 13

3.2 Biomarker Enhancement (Class IIa)

• Measure pre‑operative B‑type natriuretic peptide (BNP) or N‑terminal pro‑BNP (NT‑proBNP) in patients with RCRI ≥2 to improve discrimination.
• BNP adds a median Δc‑statistic of 0.15 to the RCRI; NT‑proBNP adds 0.08.
• Suggested abnormal thresholds: BNP > 92 ng/L; NT‑proBNP ≥ 300 ng/L.
• Combining BNP with troponin yields an additional median Δc‑statistic improvement of 0.12. 13

4. Alternative Risk Calculators

• The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) Myocardial Infarction and Cardiac Arrest (MICA) calculator should be considered for vascular surgery patients or when the RCRI is deemed insufficient. It incorporates 21 variables from the NSQIP database and provides procedure‑specific risk estimates using CPT codes. Compared with the RCRI, the MICA calculator shows a superior predictive discrimination with a median Δc‑statistic increase of ≈0.11. 13

• For thoracic surgery, the Thoracic Revised Cardiac Risk Index (ThRCRI) replaces the standard RCRI, weighting factors such as ischemic heart disease, cerebrovascular disease, serum creatinine, and pneumonectomy. 13

5. Interventions to Avoid (Class III: No Benefit)

• Routine pre‑operative coronary angiography should not be performed, as it does not improve peri‑operative outcomes. 13
• Initiating high‑dose beta‑blockers (e.g., metoprolol 100 mg) 2‑4 hours before surgery is discouraged; it is linked to higher stroke rates (1.0 % vs 0.5 %) and increased mortality (3.1 % vs 2.3 %). 13
• Routine low‑dose aspirin (≈100 mg/day) peri‑operatively should be avoided because it does not reduce cardiovascular events but raises surgical bleeding risk. 13
• Routine coronary revascularization solely to lower peri‑operative risk is not recommended. 13

6. Limitations of the RCRI and High‑Risk Populations

• The RCRI demonstrates modest discriminative ability (area under the curve ≈ 0.79). 13

• Its performance is suboptimal in vascular surgery cohorts; the NSQIP MICA calculator is preferred in this setting. 13

• Adults aged ≥ 75 years experience a higher incidence of peri‑operative MI and MACE (9.5 % vs 4.8 % in younger adults). 13
• Patients with coronary stents have an elevated peri‑operative risk (8.9 % vs 1.5 % without stents). 13
• Among the RCRI variables, a history of ischemic heart disease is the strongest independent predictor of peri‑operative adverse events. 13